Soluble Fc gamma R1a for reducing inflammation

Details for Australian Patent Application No. 2008209436 (hide)

Owner ZymoGenetics, Inc.

Inventors Ellsworth, Jeffrey L.

Agent Spruson & Ferguson

Pub. Number AU-A-2008209436

PCT Pub. Number WO2008/091682

Priority 60/886,367 24.01.07 US; 60/886,211 23.01.07 US

Filing date 23 January 2008

Wipo publication date 31 July 2008

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/091682 Priority application(s): WO2008/091682

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008209439-Method and apparatus for implementing a SIM card onboard a PC card

2008209432-Process and apparatus for generating haloamine biocides